Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA
Related Posts
Luo L, Wang X, Liao YP, Nel AE. KRAS mRNA Spleen-Targeting Lipid Nanoparticles Synergize with Irinotecan Silicasomes to Robustly Augment the Cancer Immunity Cycle in[...]
Cai X, Lee A, Ji Z, Huang C, Chang CH, Wang X, Liao YP, Xia T, Li R. Correction: Reduction of pulmonary toxicity of metal[...]
Gong F, Cui Y, Lv P, Liu J, Sun X, Han P, Zhou L, Xia T, Cao W. Role of ESCCAL-1 in regulating exocytosis of[...]